Early on, increased levels of IFN-α-induced proteins, such as 2'-5'oligoadenylate synthetase (30) and MxA (31), could also be demonstrated in the majority of SLE patients, confirming that bioactive type I IFN is produced in these patients. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.